Patent · US Active

Methods for treating lymphoid malignancies

US11622965B2 · kind B2 · utility

0Cited by
10References
23Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 26, 2018
Grant dateApr 11, 2023
Priority date
Expiry dateJan 11, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/2893
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides methods of treating lymphoid malignancies such as B cell malignancies using a BTK inhibitor in the described therapeutic regimens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.